Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders diagnosed in the United States, with the most recent estimates of prevalence at 1 in 68 children. Maternal inflammation during pregnancy is 1 prenatal environmental factor that has been associated with ASD risk in children.
| INTRODUC TI ON
Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders diagnosed in the United States, with the most recent estimates of prevalence at 1 in 68 children. 1 While the core symptoms range in severity, all individuals with ASD experience clinically significant impairment in functioning resulting from persistent deficits in social interactions and/or communication as well as repetitive patterns of behaviors or actions. 2 The development of ASD can be significantly influenced by genetic factors, although differences in study methodology (eg, sample selection, diagnostic strategy, and data analytic methods) have resulted in substantial variation in estimates of genetic contributions. [2] [3] [4] [5] Importantly, several perinatal exposures, including infections and environmental toxins, have also been implicated in conferring risk for ASD, and the contribution of these and related environmental factors to the etiology of the disorder have received increasing attention in the past decade. [6] [7] [8] [9] [10] [11] Maternal inflammation during pregnancy is 1 prenatal environmental factor that has been associated with ASD risk in children. 9, 12 High levels of maternal prenatal circulating pro-inflammatory cytokines, including interleukin-6 (IL-6), interferon gamma (IFNg), and IL-1alpha, have been associated with ASD with comorbid intellectual disability in offspring, 13 while high levels of maternal circulating IFNg, IL-4, and IL-5 have been associated with ASD regardless of comorbid intellectual disability status. 14 The most obvious cause of maternal inflammation is infection, and indeed, a study by Atladottir and associates (2010) determined that pregnant women admitted to the hospital for treatment of infections had greater risk of offspring being diagnosed with ASD. 15 Interestingly, this study also found that mothers hospitalized for viral infections, specifically in the first trimester, had 3 times greater risk of having a child diagnosed with ASD. 15 Despite this, the effects of maternal viral infections during pregnancy have remained understudied. 10 The only maternal viral infection to receive significant consideration in the context of its indirect effects on fetal development is influenza. Seasonal and pandemic influenza strains rarely infect the fetus, 16 yet they have been associated with numerous neurodevelopmental outcomes, including ASD and schizophrenia. 10, [17] [18] [19] [20] But unlike influenza, many common viral infections, such as cytomegalovirus (CMV) and herpes simplex virus 2 (HSV2) infections, are asymptomatic and do not result in hospitalization. But despite being subclinical, these viruses still induce an immune response. [21] [22] [23] [24] [25] [26] [27] [28] In addition, they establish latency and can be persistently reactivated throughout the lifetime of the host. 29 This means that women seropositive for CMV or HSV2 harbor the latent virus, which can become reactivated at any time. Unfortunately, little is known of how reactivation of these viruses affects the maternal immune system and what consequences they might have on fetal neurodevelopment and ASD.
Therefore, we designed this study with the goal of determining if mothers who were CMV or HSV2 sero-positive had children who displayed higher levels of ASD symptoms. We used a nested sample (n = 82) within the ARCH cohort, a longitudinal pregnancy cohort recruited from 2 clinics in Lansing, Michigan. Maternal viral serostatus was determined by detection of CMV and/or HSV2 IgG in maternal serum collected at the first prenatal visit. The symptoms of ASD were assessed in children using the parent-reported Social
Responsiveness Scale version 2 (SRS-2) questionnaire, a pre-clinical ASD assessment tool. 30 Linear regression models were used to assess the relationship between maternal viral serostatus and ASD symptoms in children. by child age and sex and has evidence of good inter-rater reliability, high internal consistency, and convergent validity with the Autism Diagnostic Interview-Revised (ADI-R). 30 The SRS-2 scores were used as a continuous outcome variable, as opposed to using ASD diagnosis as a categorical outcome, due to limited sample size, and also in order to identify exposures that influence the entire range of autism-related symptoms.
| ME THODS

| Study cohort
While the SRS-2 has been widely used to assess ASD symptoms, scores can be inflated due to unrelated behavioral problems. For that reason, the Child Behavior Checklist (CBCL) was used to assess more general maladaptive functioning and behavior problems. 32, 33 Scores in the broadband domains of internalizing (CBCL IB; ie, depression, anxiety, social withdrawal, and somatic complaints) and externalizing (CBCL EB; ie, aggression and rule-breaking) were used to adjust SRS-2 score for behavioral problems in these other domains.
The Broad Autism Phenotype Questionnaire (BAPQ) was used to assess aloofness, rigid personality, and pragmatic language deficits that are characteristic of the broader autism phenotype (BAP) in mothers. 34 BAP traits are qualitatively similar to autistic symptoms, but are subclinical. These characteristics have been previously identified in mothers of autistic children, and maternal BAP is considered an indication of genetic liability for autism. A normative BAPQ cutoff score of 3.1 was previously established for mothers. 
| Qualitative analysis of maternal antibodies using ELISA
Maternal serum was thawed on ice, diluted 1:100, and assayed using colorimetric ELISA developed for qualitative analysis of CMV IgG (ab108724; Abcam, Cambridge, MA, USA) and HSV2 IgG (ab108739;
Abcam) according to the manufacturer's protocol. Briefly, samples were diluted and incubated in microplates that were pre-coated with viral antigen, which served to "capture" virus-specific antibodies present in the serum. Following incubation, plates were washed and then incubated with horseradish peroxidase (HRP)-conjugated antibodies specific to CMV or HSV2 IgG. Finally, plates were washed, HRP substrate was added for 15 minutes, and the reaction was quenched. The sample absorbance was measured at 450 nm, and a cutoff control provided by the assay manufacturer was used to determine whether women were sero-positive for CMV or HSV2.
| Data analysis
The characteristics of the analytic sample (eg, race/ethnicity, maternal age, parity, and behavior scores.) were described as frequencies or means and standard deviations. 
| RE SULTS
| Study protocol and sample characteristics
We tested the hypothesis that mothers sero- The characteristics of our analytic sample are reported in Table 1 . In total, 53% of our sample was CMV sero-positive (IgG) and 21% were HSV2 (IgG) sero-positive, and the mean SRS-2 score was 53.1 (SD 8.7). Maternal and pregnancy characteristics were further evaluated according to CMV and HSV2 seroprevalence and are reported in Table 2 . HSV2 frequency was significantly higher in African American and Hispanic women than in non-Hispanic White women (Table 2 )(chi-squared test, P = .02) and was greatest in older women (Table 2 )(chi-squared test, P < .001). CMV frequency did not significantly differ across maternal and pregnancy characteristics.
F I G U R E 1 Schematic representation of study protocol. Pregnant women who were 18 y of age or older, and Englishspeaking, were recruited during their first prenatal visit at 2 clinics in Lansing, MI. Maternal demographic and pregnancy information was gathered, and serum was collected following patient consent. Maternal viral serostatus was evaluated using these first-trimester serum specimens. Child behavior assessments were performed between 3 and 6 y of age, using parent-reported SRS-2 and CBCL scores. The relationship between maternal serostatus and child behavior scores was evaluated using unadjusted and adjusted linear regression 
| Maternal CMV IgG is associated with ASD symptoms in children
Linear regression was used to evaluate the relationship between maternal viral serostatus and ASD symptoms in children. Maternal CMV IgG was associated with higher levels of ASD symptoms in children (Unadjusted Model, CMV; Table 3 ), and this effect was not driven by SRS-2 score outliers (n = 2, >1.5*IQR). However, there was no significant relationship between maternal HSV2 serostatus and ASD symptoms (Unadjusted Model, HSV2; Table 3 ). Next, the above models were adjusted for sample characteristics for which there were differences in viral prevalence and for those implicated in prior reports. Specifically, we adjusted for maternal age, race/ethnicity, education level, 36 maternal BAP, 37 parity, 38 and child sex. 39 The association between CMV sero-positivity and ASD symptoms persisted following these adjustments (Adjusted Model 1, CMV; Table 3 ), and the association between HSV2 and ASD symptoms remained non-significant (Adjusted Model 1, HSV2; Table 3 ). We further adjusted for CBCL IB and CBCL EB scores as these behaviors may inflate SRS-2 scores in children with behavioral problems unrelated to ASD. The significant association between CMV sero-positivity and ASD symptoms persisted following these adjustments, and the outcome effect was greater (Adjusted Model 2, β = 4.3 vs Adjusted Model 1, β = 3.6). The association between HSV2 and ASD symptoms remained non-significant (Adjusted Model 2, HSV2; Table 3 ).
Finally, because behavior scores were analyzed as continuous variables, and not dichotomized into referent/clinical categories, we removed children with clinically elevated SRS-2 scores (ie, ≥60; n = 17)
and repeated the analyses. We did this to confirm that associations between viral serostatus and SRS-2 scores were largely driven by children with clinically significant ASD symptoms. Indeed, this was confirmed; removing those cases with elevated SRS-2 scores resulted in attenuation of the unadjusted and fully adjusted findings by 63% and 53%, respectively, and there was no longer an association between maternal CMV sero-positivity and SRS-2 scores.
| D ISCUSS I ON
The genital CMV infection is rare, estimated to occur in 0.5%-2.0% of births despite the fact that 60%-90% of women are CMV seropositive. 43 Therefore, the majority of maternal CMV infections do not result in viral transmission to the fetus. However, the virus can still indirectly affect the fetus by affecting maternal immunity Characteristics of analytic sample (n = 82) derived from the ARCH Child Development Cohort (N = 132), after excluding premature labor (<37 wk), twin samples, and samples missing maternal serum or child SRS-2/CBCL behavioral assessments (n = 82).
TA B L E 1 Maternal, pregnancy and child sample characteristics and/or placental function. It is the indirect effects of these infections on neurodevelopmental outcomes such as ASD that remain unknown.
Viruses from the family Herpesviradae include many common human pathogens such as CMV and HSV2. One important characteristic of these viruses is that, after primary infection, they TA B L E 2 Maternal and pregnancy characteristics and viral serostatus (27) 10 (24) 19 (30) 1 (7) ≥$50 000 8 (22) 6 (14) 10 (16) Cytomegalovirus infection affects CD8 T-cell function, 22, 23 and there is evidence that CD8 cells play a role in perinatal brain injury. 45 At the maternal-fetal interface, CMV can affect natural killer cell function, 28 induce local macrophage and T-cell infiltration, 46 and disrupt trophoblast invasion, 47 proliferation, 47 and immune function. 24, 26, 27 These observations formed the rationale for the present study.
If pregnancy-related stress can increase the risk for persistent viral reactivations, leading to chronic immune activation in the mother, this could have negative consequences on fetal brain development.
If this were the case, as we hypothesize, then children from mothers harboring these latent viruses would exhibit higher levels of ASD symptoms compared to children from sero-negative mothers.
Here, we tested that hypothesis and determined that, indeed, maternal CMV sero-positivity was associated with more severe ASD symptoms in children. As we assessed maternal viral serostatus, which indicates past infection and not necessarily active infection, this study does not link active infection to ASD symptoms. But because CMV established latency, these findings suggest that harboring the latent virus could be associated with ASD symptoms. A direct role for the virus, and maternal immune activation, in these outcomes, has yet to be determined and is the focus of ongoing work.
Few other studies have investigated the effect of maternal viral infections, rather than congenital viral infections, on neurodevelopmental outcomes. Indeed, only 1 recent study has investigated the association between maternal CMV and HSV2 serostatus during pregnancy and ASD diagnosis in children. 48 In that study, HSV2 was determined to be associated with ASD, but only when HSV2 IgG was analyzed as a continuous variable.
Unfortunately, these results are difficult to interpret because the assay used to determine HSV2 serostatus is strictly qualitative, and it is inappropriate to analyze HSV2 IgG on a continuous scale. That study also did not find an association between maternal CMV serostatus and ASD in children. The disparate results between that study and ours are likely due to significant differences in outcome reporting and analysis. In the previous study, ASD was analyzed as a categorical variable and children with ASD were identified through multiple mechanisms including screening via parent questionnaires at 3, 5, and 7 years of age, professional and parent referrals of participants suspected of having ASD, linkages through the Norwegian Patient Register, and a subset of children that were clinically diagnosed at a clinic. 48 These represent a broad range of diagnostic protocols, some of which depend on treatment-seeking behaviors. These factors can contribute a considerable amount of variation to ASD diagnoses, making it increasingly difficult to study associations, especially in higher functioning individuals.
In conclusion, we determined that maternal CMV seropositivity was associated with ASD symptoms in children. An important limitation of this study was the small sample size;
therefore, future studies with larger samples will be required to confirm and further evaluate these findings. Further evaluation of CMV activation, and the associated maternal immune response, will also be important next steps for understanding the mechanisms by which maternal viral exposures influence the development of ASD. 
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